A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis. [electronic resource]
Producer: 19990212Description: 362-9 p. digitalISSN:- 0161-6420
- Adult
- Aged
- Androstadienes -- administration & dosage
- Anti-Allergic Agents -- administration & dosage
- Anti-Inflammatory Agents -- administration & dosage
- Conjunctivitis, Allergic -- drug therapy
- Double-Blind Method
- Female
- Humans
- Intraocular Pressure -- drug effects
- Loteprednol Etabonate
- Male
- Middle Aged
- Ophthalmic Solutions -- administration & dosage
- Prospective Studies
- Safety
- Seasons
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.